{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:47:27Z","timestamp":1784371647282,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA295336"],"award-info":[{"award-number":["U54CA295336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.radonc.2025.111130","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:05:58Z","timestamp":1757549158000},"page":"111130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy and safety of twice-daily accelerated hyperfractionated re-irradiation for thoracic malignancies"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6682-2158","authenticated-orcid":false,"given":"Victoria L.","family":"Doss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia F.P.M.","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3355-2524","authenticated-orcid":false,"given":"Elaina","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinker","family":"Trent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9856-3947","authenticated-orcid":false,"given":"Esi","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsion","family":"Gebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6596-7541","authenticated-orcid":false,"given":"Anas","family":"Obaideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meti","family":"Negassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4815-0537","authenticated-orcid":false,"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-1211","authenticated-orcid":false,"given":"K.Ranh","family":"Voong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-2909","authenticated-orcid":false,"given":"Xun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell K.","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111130_b0005","first-page":"152","article-title":"Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles","volume":"3","author":"Nieder","year":"2013","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.radonc.2025.111130_b0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.adro.2019.05.007","article-title":"The special medical physics consult process for reirradiation patients","volume":"4","author":"Paradis","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109947","article-title":"Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform","volume":"189","author":"Willmann","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0020","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","article-title":"High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer","volume":"15","author":"De Ruysscher","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lungcan.2015.02.008","article-title":"High-dose conventional thoracic re-irradiation for lung cancer: updated results","volume":"88","author":"Tetar","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.111130_b0030","first-page":"75","article-title":"Thoracic reirradiation for lung cancer: a literature review and practical guide","volume":"3","author":"Drodge","year":"2014","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.radonc.2025.111130_b0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clon.2017.11.003","article-title":"Re-irradiation for locally recurrent lung cancer: evidence, risks and benefits","volume":"30","author":"Rulach","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030573","article-title":"High dose thoracic re-irradiation and chemo-immunotherapy for centrally recurrent NSCLC","volume":"14","author":"Grambozov","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.111130_b0045","first-page":"76","article-title":"Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer","volume":"22","author":"Yang","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0050","article-title":"An international expert survey on the indications and practice of radical thoracic reirradiation for non-small cell lung cancer","volume":"6","author":"Rulach","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.03.056","article-title":"American radium society (ARS) and American college of radiology (ACR) appropriate use criteria systematic review and guidelines on reirradiation for non-small cell lung cancer (NSCLC)","author":"Simone","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111130_b0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ctrv.2010.04.004","article-title":"Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain","volume":"36","author":"Marcu","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.radonc.2025.111130_b0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2009.04.056","article-title":"Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation","volume":"77","author":"Das","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111130_b0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(23)00269-6","article-title":"Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial","volume":"401","author":"You","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111130_b0075","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/curroncol28030170","article-title":"Re-irradiation for locally recurrent lung cancer: a single center retrospective analysis","volume":"28","author":"Grambozov","year":"2021","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2025.111130_b0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.21037\/tlcr.2020.01.19","article-title":"Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer\u2014a multicenter study","volume":"9","author":"K\u00e4smann","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.radonc.2025.111130_b0085","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European society for radiotherapy and oncology and european organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111130_b0090","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 5.0. 2017."},{"key":"10.1016\/j.radonc.2025.111130_b0095","unstructured":"National Cancer Institute. Adverse event reporting requirements. 2024."},{"key":"10.1016\/j.radonc.2025.111130_b0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.lungcan.2013.12.006","article-title":"High-dose, conventionally fractionated thoracic reirradiation for lung tumors","volume":"83","author":"Griffioen","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.111130_b0105","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4143\/crt.2018.472","article-title":"High-dose thoracic re-irradiation of lung cancer using highly conformal radiotherapy is effective with acceptable toxicity","volume":"51","author":"Hong","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.111130_b0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00066-019-01457-2","article-title":"Re-irradiation in locally recurrent lung cancer patients","volume":"195","author":"Schlampp","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111130_b0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtho.2016.10.018","article-title":"Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent Non-Small cell lung cancer","volume":"12","author":"Chao","year":"2016","journal-title":"J Thor Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2025.111130_b0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2014.07.030","article-title":"Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes","volume":"90","author":"Mcavoy","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111130_b0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Frequency of thoracic radiotherapy with chemotherapy in limited small-cell lung cancer twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.radonc.2025.111130_b0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.prro.2017.07.002","article-title":"Reirradiation of thoracic cancers with intensity modulated proton therapy","volume":"8","author":"Ho","year":"2018","journal-title":"Pract Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:19:36Z","timestamp":1780114776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025046341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"alternative-id":["S0167814025046341"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111130","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of twice-daily accelerated hyperfractionated re-irradiation for thoracic malignancies","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111130"}}